Jili Sun

Title: Jili Sun: Innovator in Pharmaceutical Compositions

Introduction

Jili Sun is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to pharmaceutical compositions. His work focuses on enhancing the effectiveness of drug delivery systems.

Latest Patents

Jili Sun holds a patent for "Pharmaceutical compositions comprising nitroxoline lysinate, preparation method therefor and use thereof." This invention involves pharmaceutical compositions that consist of a first layer and a second layer. The first layer includes 40%-70% of active pharmaceutical ingredient, 10%-30% of filler, 5%-12% of disintegrant, 0.5%-2% of lubricant, 0.1%-1.5% of glidant, and 10%-20% of alkaline substance. The second layer comprises 40%-70% of active pharmaceutical ingredient, 10%-30% of filler, 10%-35% of sustained-release material, 0.1%-2% of lubricant, and 0.1%-2% of glidant. The active pharmaceutical ingredient can be selected from nitroxoline lysinate, its crystalline form, or solvate. This composition is designed to achieve burst release at an early stage and sustained release at a later stage.

Career Highlights

Throughout his career, Jili Sun has worked with prominent companies in the pharmaceutical industry. He has been associated with Asieris Pharmaceuticals and Jiangsu Yahong Meditech. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Jili Sun has collaborated with several professionals in his field, including Yushen Guo and Shuai Shen. These collaborations have likely enhanced his research and development efforts in pharmaceutical compositions.

Conclusion

Jili Sun is a distinguished inventor whose work in pharmaceutical compositions has the potential to significantly impact drug delivery systems. His innovative approach to formulating effective pharmaceutical products showcases his dedication to advancing healthcare solutions.